TickerGuard
Buy Day today: Neutral (58) Mixed market breadth · no major macro event
OGN

Organon & Co

Healthcare · Drug Manufacturers - General

13.70$ -0.1% vs. previous close Closing price · As of: Oct 5, 2026

Statements

Cash Flow

Organon & Co (OGN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at 107 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow OGN
Line item Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
666 803 288 430 735 1,472 368 47 123 151 317 267 114 27 261 397 76 332 141 390 75 220 264 141 225 107 737
33 34 40 50 38 43 52 62 53 50 57 52 57 58 61 60 65 66 69 77 84 89 92 240 86 -86 332
10 11 11 22 11 18 15 15 15 19 18 23 22 25 27 27 26 28 25 26 24 22 24 7.0 19 -19 31
-55 150 193 – 193 4.0 2.0 11 11 110 8.0 52 43 26 52 – – – – – – – – – – – –
-15 71 -152 40 105 998 -9.0 -228 -289 -243 25 55 -163 -307 90 225 -223 -301 -167 112 -125 -61 -27 -34 42 -42 -61
40 47 47 144 38 59 61 138 63 45 215 65 54 71 55 81 96 32 76 132 97 39 115 45 37 42 239
-49 -41 -50 -118 -38 -249 -61 -133 -63 -83 -213 -420 -54 -70 -179 -81 -96 -46 -75 -296 -172 -38 -115 -65 386 -76 130
– – 74 – 74 74 74 71 71 72 74 73 73 74 74 73 70 79 74 74 71 10 3.0 4.0 5.0 6.0 18
– – – – – – – – – -8.0 -3.0 – -1.0 -12 -2.0 -2.0 -2.0 -14 -2.0 -4.0 -1.0 -12 -1.0 – – – –
-566 -566 -566 – -566 8,524 -10 -102 -2.0 -104 -2.0 -2.0 -252 -2.0 -2.0 – – – -2.0 -2.0 -3.0 -201 -72 -182 -32 0.0 -286
-618 -577 -303 -677 -592 -700 -18 -187 -91 -183 -77 -82 -326 -88 -78 -77 -74 -134 -78 -82 -75 -223 -76 -187 -38 -12 -313
1.0 124 -63 -311 129 589 278 -271 -43 -149 -46 207 -247 -133 88 279 -118 129 59 -88 -128 52 73 -98 542 16 533
626 756 241 286 697 1,413 307 -91 60 106 102 202 60 -44 206 316 -20 300 65 258 -22 181 149 96 188 65 498

LTM = last twelve months (sum of the four most recent quarters).

Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?